Key Points
- CEO Sean Duffy sold 12,944 Omada Health shares at an average price of $20.40, generating $264,057.60. The sale reduced his direct holdings by 3.05% to 411,861 shares.
- Omada Health shares were trading at $19.11, down 5.3%, with a market capitalization of approximately $1.14 billion. The company recently reported quarterly revenue of $78.05 million and an adjusted loss of $0.05 per share, better than estimates.
- Analyst sentiment remains broadly positive, with 11 Buy ratings, two Holds and one Sell; the consensus rating is “Moderate Buy,” with an average price target of $24.75.
Omada Health, Inc. (NASDAQ:OMDA - Get Free Report) CEO Sean Duffy sold 12,944 shares of the firm's stock in a transaction that occurred on Monday, August 3rd. The shares were sold at an average price of $20.40, for a total transaction of $264,057.60. Following the transaction, the chief executive officer directly owned 411,861 shares in the company, valued at approximately $8,401,964.40. The trade was a 3.05% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website.
Omada Health Trading Down 5.3%
Shares of NASDAQ:OMDA opened at $19.11 on Thursday. The stock has a market capitalization of $1.14 billion, a PE ratio of -70.78 and a beta of 1.73. Omada Health, Inc. has a 1 year low of $10.28 and a 1 year high of $26.92. The firm has a fifty day moving average price of $20.21 and a 200 day moving average price of $16.12.
Omada Health (NASDAQ:OMDA - Get Free Report) last announced its quarterly earnings results on Thursday, May 7th. The company reported ($0.05) EPS for the quarter, beating the consensus estimate of ($0.08) by $0.03. Omada Health had a negative return on equity of 1.82% and a negative net margin of 2.22%.The company had revenue of $78.05 million for the quarter. On average, sell-side analysts forecast that Omada Health, Inc. will post -0.01 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
Hedge funds have recently bought and sold shares of the stock. Geode Capital Management LLC bought a new position in Omada Health in the 2nd quarter valued at $637,000. Walleye Capital LLC bought a new stake in shares of Omada Health during the second quarter worth $458,000. Ilex Capital Partners UK LLP bought a new stake in shares of Omada Health during the second quarter worth $201,000. Soros Fund Management LLC acquired a new stake in shares of Omada Health in the second quarter valued at $640,000. Finally, Raymond James Financial Inc. bought a new position in shares of Omada Health in the second quarter valued at about $32,000.
Wall Street Analyst Weigh In
A number of equities analysts recently issued reports on the stock. Morgan Stanley reaffirmed an "overweight" rating and set a $30.00 target price on shares of Omada Health in a research report on Monday, June 22nd. Citigroup reissued an "outperform" rating on shares of Omada Health in a report on Monday, July 20th. Needham & Company LLC restated a "buy" rating and issued a $28.00 price target on shares of Omada Health in a research report on Friday, May 8th. BTIG Research began coverage on shares of Omada Health in a report on Friday, July 17th. They set a "buy" rating and a $30.00 price objective on the stock. Finally, Weiss Ratings lowered shares of Omada Health from a "sell (d-)" rating to a "sell (e+)" rating in a research report on Monday, July 13th. Eleven research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $24.75.
Get Our Latest Stock Analysis on Omada Health
Omada Health Company Profile
(
Get Free Report)
Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company's platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.
In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
